Samphire Neuroscience

📍 London, United Kingdom🗓 Founded 2021👥 20 employees💰 Last funded Jan 2025
Medical Equipment Manufacturing🌐 samphireneuro.com
Website LinkedIn
At Samphire Neuroscience, were on a mission to transform womens health through brain based innovation. Our vision is simple: to create a world where women have access to medical grade solutions that empower them to take control of their health—without compromising on technology, design, or lifestyle. Building on over 30 years of research and clinical expertise, we’ve developed Nettle, the worlds first brain stimulating headband for the at-home alleviation of PMS and period pain symptoms. Samphire Neuroscience also offers neuroscience-backed cycle tracking via the Samphire app, available on the Apple App Store and Google Play.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2021
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Samphire Neuroscience?
Samphire Neuroscience has 2 investors on record on gritt.io, 2 mid-stage.
When did Samphire Neuroscience last raise funding?
The most recent investment in Samphire Neuroscience recorded on gritt.io was in January 2025.
When was Samphire Neuroscience founded?
Samphire Neuroscience was founded in 2021.
What industry is Samphire Neuroscience in?
Samphire Neuroscience operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Samphire Neuroscience based?
Samphire Neuroscience is headquartered in London, United Kingdom.